Skip to content

Molnupiravir

Published: July 26, 2026Updated: August 20, 2026

Molnupiravir is an oral antiviral medication designed to treat mild-to-moderate COVID-19 in adults at high risk for progressing to severe disease. It works by introducing errors into the SARS-CoV-2 viral RNA during replication, preventing the virus from multiplying effectively.

Quick summary

An oral antiviral drug used to treat COVID-19 in high-risk patients by causing viral RNA errors during replication.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy
BOXED WARNING

This medication carries a boxed (black box) warning — the strongest type of FDA warning. Review the full prescribing information before use.

Key facts at a glance

ATC
J05AB18
RxNorm
2587901
Generic
Molnupiravir
Class
atc-j05
Brands
Lagevrio
Availability
rx
Lactation
unknown
Routes
oral
Forms
capsule
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Treatment of mild-to-moderate COVID-19 in adults with positive SARS-CoV-2 test results who are at high risk for progressing to severe COVID-19, including hospitalization or death.

Molnupiravir is a prodrug that is metabolized into NHC (cytidine nucleoside analogue), which enters cells and is phosphorylated to form the active triphosphate form (NHC-TP). This active metabolite incorporates into viral RNA during replication, causing lethal mutagenesis and preventing viral spread.

Typically initiated within 5 days of symptom onset. Not authorized for use in patients younger than 18 years, for prevention of COVID-19, or for severe/critical cases requiring hospitalization. Should not be used during pregnancy. Complete the full treatment course as prescribed.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy